Adam Flegg

630 total citations
4 papers, 498 citations indexed

About

Adam Flegg is a scholar working on Molecular Biology, Geriatrics and Gerontology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Adam Flegg has authored 4 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Geriatrics and Gerontology and 1 paper in Cellular and Molecular Neuroscience. Recurrent topics in Adam Flegg's work include Ion channel regulation and function (2 papers), Sirtuins and Resveratrol in Medicine (2 papers) and Cardiac electrophysiology and arrhythmias (1 paper). Adam Flegg is often cited by papers focused on Ion channel regulation and function (2 papers), Sirtuins and Resveratrol in Medicine (2 papers) and Cardiac electrophysiology and arrhythmias (1 paper). Adam Flegg collaborates with scholars based in United Kingdom, Germany and France. Adam Flegg's co-authors include Russell J. Thomas, Patricia Amouzegh, Jeffrey O. Saunders, Peter S. DiStefano, Rory Curtis, Kenneth Keavey, Jeffrey Hixon, Jean‐François Pons, Manuel A. Navia and Michael J. Kates and has published in prestigious journals such as Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Adam Flegg

4 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Adam Flegg United Kingdom	4	273	191	130	103	88	4	498
Patricia Amouzegh United Kingdom	6	273 1.0×	169 0.9×	130 1.0×	104 1.0×	87 1.0×	7	500
Michael J. Kates United States	7	271 1.0×	206 1.1×	132 1.0×	166 1.6×	86 1.0×	8	551
David P. Carney United States	8	463 1.7×	194 1.0×	209 1.6×	86 0.8×	106 1.2×	8	689
Yunyi Hong China	11	196 0.7×	169 0.9×	113 0.9×	11 0.1×	98 1.1×	14	420
Xuemin Sun United States	6	90 0.3×	230 1.2×	56 0.4×	11 0.1×	33 0.4×	7	420
Isak Im South Korea	12	23 0.1×	295 1.5×	33 0.3×	147 1.4×	20 0.2×	16	534
Sylvia Aust Austria	11	89 0.3×	147 0.8×	34 0.3×	10 0.1×	9 0.1×	14	356
Keng Gat Lim United Kingdom	11	27 0.1×	619 3.2×	47 0.4×	49 0.5×	27 0.3×	11	685
Hanjie Jiang United States	11	20 0.1×	262 1.4×	33 0.3×	34 0.3×	12 0.1×	24	395
Somi Reddy Majjigapu Switzerland	8	25 0.1×	245 1.3×	30 0.2×	112 1.1×	44 0.5×	12	549

Countries citing papers authored by Adam Flegg

Since Specialization

Citations

This map shows the geographic impact of Adam Flegg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Flegg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Flegg more than expected).

Fields of papers citing papers by Adam Flegg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Flegg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Flegg. The network helps show where Adam Flegg may publish in the future.

Co-authorship network of co-authors of Adam Flegg

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Flegg. A scholar is included among the top collaborators of Adam Flegg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Flegg. Adam Flegg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

East, Stephen P., Christian Eickmeier, Adam Flegg, et al.. (2010). An orally bioavailable positive allosteric modulator of the mGlu4 receptor with efficacy in an animal model of motor dysfunction. Bioorganic & Medicinal Chemistry Letters. 20(16). 4901–4905. 36 indexed citations

2.

Moss, Neil, Younggi Choi, Derek A. Cogan, et al.. (2009). A new class of 5-HT2B antagonists possesses favorable potency, selectivity, and rat pharmacokinetic properties. Bioorganic & Medicinal Chemistry Letters. 19(8). 2206–2210. 22 indexed citations

3.

Napper, Andrew D., Jeffrey Hixon, Thomas McDonagh, et al.. (2007). Discovery of Indoles as Potent and Selective Inhibitors of the Deacetylase SIRT1.. Journal of Medicinal Chemistry. 50(5). 1086–1086. 4 indexed citations

4.

Napper, Andrew D., Jeffrey Hixon, Thomas McDonagh, et al.. (2005). Discovery of Indoles as Potent and Selective Inhibitors of the Deacetylase SIRT1. Journal of Medicinal Chemistry. 48(25). 8045–8054. 436 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact